Molecular Partners (MOLN) Earnings Date, Estimates & Call Transcripts $3.74 -0.16 (-4.08%) As of 11:41 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Molecular Partners Earnings Summary Upcoming Earnings DateMay. 15Before Market OpensEstimatedConsensus EPS (Mar. 6) -$0.45 Actual EPS (Mar. 6) -$0.34 Beat By $0.11 Molecular Partners issued H2 2024 earnings on March 6, 2025, reporting an EPS of -$0.34, which topped analysts' consensus estimates of -$0.45 by $0.11. With a trailing EPS of -$1.81, Molecular Partners' earnings are expected to decrease next year, from ($1.93) to ($2.08) per share. H2 2024 Earnings ResourcesH2 2024 Earnings ReportConference Call Transcript & Audio Annual Report (20-F) Slide Deck Press Release (6-K)MOLN Upcoming EarningsMolecular Partners' next earnings date is estimated for Thursday, May 15, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Molecular Partners Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Molecular Partners and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMOLN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MOLN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Molecular Partners Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($1.93) EPSNext Year EPS Consensus Estimate ($2.08) EPS Molecular Partners Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/15/2025(Estimated)--------3/6/2025H2 2024-$0.45-$0.34+$0.11-$0.34--10/31/2024--$0.63-$0.57+$0.06-$0.57-$0.79M8/26/2024H1 2024--$0.51 -$0.51-$0.51-$1.72M5/16/2024Q1 2024--$0.39 -$0.39-$0.39-$3.13M3/14/2024H2 2023--$0.68 -$0.68-$0.68-$1.17M10/26/2023Q3 2023--$0.40 -$0.40-$0.40-$2.88M8/23/2023H1 2023--$0.55 -$0.55-$0.55-$0.46M5/12/2023Q1 2023--$0.49 -$0.49-$0.49-$3.30M Molecular Partners Earnings - Frequently Asked Questions When is Molecular Partners's earnings date? Molecular Partners has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 15th, 2025 based off last year's report dates. Learn more on MOLN's earnings history. Did Molecular Partners beat their earnings estimates last quarter? In the previous quarter, Molecular Partners (NASDAQ:MOLN) reported ($0.34) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.11. Learn more on analysts' earnings estimate vs. MOLN's actual earnings. How can I listen to Molecular Partners's earnings conference call? The conference call for Molecular Partners's latest earnings report can be listened to online. Listen to Conference Call How can I read Molecular Partners's conference call transcript? The conference call transcript for Molecular Partners's latest earnings report can be read online. Read Transcript How much revenue does Molecular Partners generate each year? Molecular Partners (NASDAQ:MOLN) has a recorded annual revenue of $4.97 million. How much profit does Molecular Partners generate each year? Molecular Partners (NASDAQ:MOLN) has a recorded net income of -$69.04 million. MOLN has generated -$1.81 earnings per share over the last four quarters. What is Molecular Partners's EPS forecast for next year? Molecular Partners's earnings are expected to decrease from ($1.93) per share to ($2.08) per share in the next year. More Earnings Resources from MarketBeat Related Companies AnaptysBio Earnings Results KalVista Pharmaceuticals Earnings Results Arbutus Biopharma Earnings Results Trevi Therapeutics Earnings Results AbCellera Biologics Earnings Results ChromaDex Earnings Results Pharming Group Earnings Results Organogenesis Earnings Results CorMedix Earnings Results Bicycle Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of EarningsAmazon's Earnings Will Make or Break the Stock's Comeback CrowdStrike Stock Nears Record High, Dip Ahead of Earnings?Alphabet Rebounds After Strong Earnings and Buyback AnnouncementMarkets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings? This page (NASDAQ:MOLN) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Partners AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MOLN Stock Free MOLN Stock Alerts